BACKGROUND: Gestational diabetes mellitus (GDM) is a risk factor for mothers to develop type 2 diabetes (T2D) postpartum, and for their children to develop obesity. The aim of the ongoing POGO study is to identify long-lasting changes in the maternal and fetal metabolism and microbiome, after GDM, which contribute to subsequent development of T2D and obesity. METHODS: Women screened for GDM are asked to attend a postpartum study visit together with their offspring. At the visit, demographic, nutritional, and anthropometric data are recorded. Additionally, data about physical activity, metabolism, and genetic susceptibility are collected using accelerometers, breath gas analyses, 75g oral glucose tolerance tests (OGTT), and bio-samples such as blood and stool. RESULTS: To date, 121 women (median follow-up time postpartum: 5.5 years) have been enrolled together with 133 index children. GDM has been diagnosed using OGTT in 105 women (and 117 children). It showed that 47 mothers had abnormal glucose tolerance, including 19 cases of impaired glucose tolerance, 19 of impaired fasting glucose, eight with T2D, and one with type 1 diabetes (T1D). The prevalence of obesity in the offspring of GDM mothers was 5.1%. Of 61 children tested by OGTT, three were diagnosed with impaired glucose tolerance, another three with impaired fasting glucose, and none with T1D or T2D. CONCLUSIONS: The POGO study will contribute to the understanding of the pathogenesis of T2D and obesity after GDM, and will thus help to develop appropriate prevention and intervention strategies. This article presents the first results of the ongoing study, which are looking promising.
BACKGROUND:Gestational diabetes mellitus (GDM) is a risk factor for mothers to develop type 2 diabetes (T2D) postpartum, and for their children to develop obesity. The aim of the ongoing POGO study is to identify long-lasting changes in the maternal and fetal metabolism and microbiome, after GDM, which contribute to subsequent development of T2D and obesity. METHODS:Women screened for GDM are asked to attend a postpartum study visit together with their offspring. At the visit, demographic, nutritional, and anthropometric data are recorded. Additionally, data about physical activity, metabolism, and genetic susceptibility are collected using accelerometers, breath gas analyses, 75g oral glucose tolerance tests (OGTT), and bio-samples such as blood and stool. RESULTS: To date, 121 women (median follow-up time postpartum: 5.5 years) have been enrolled together with 133 index children. GDM has been diagnosed using OGTT in 105 women (and 117 children). It showed that 47 mothers had abnormal glucose tolerance, including 19 cases of impaired glucose tolerance, 19 of impaired fasting glucose, eight with T2D, and one with type 1 diabetes (T1D). The prevalence of obesity in the offspring of GDM mothers was 5.1%. Of 61 children tested by OGTT, three were diagnosed with impaired glucose tolerance, another three with impaired fasting glucose, and none with T1D or T2D. CONCLUSIONS: The POGO study will contribute to the understanding of the pathogenesis of T2D and obesity after GDM, and will thus help to develop appropriate prevention and intervention strategies. This article presents the first results of the ongoing study, which are looking promising.
Authors: E Opper; A Worth; M Wagner; K Bös Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2007 May-Jun Impact factor: 1.513
Authors: Robert Barouki; Peter D Gluckman; Philippe Grandjean; Mark Hanson; Jerrold J Heindel Journal: Environ Health Date: 2012-06-27 Impact factor: 5.984
Authors: Sophie Molnos; Simone Wahl; Mark Haid; E Marelise W Eekhoff; René Pool; Anna Floegel; Joris Deelen; Daniela Much; Cornelia Prehn; Michaela Breier; Harmen H Draisma; Nienke van Leeuwen; Annemarie M C Simonis-Bik; Anna Jonsson; Gonneke Willemsen; Wolfgang Bernigau; Rui Wang-Sattler; Karsten Suhre; Annette Peters; Barbara Thorand; Christian Herder; Wolfgang Rathmann; Michael Roden; Christian Gieger; Mark H H Kramer; Diana van Heemst; Helle K Pedersen; Valborg Gudmundsdottir; Matthias B Schulze; Tobias Pischon; Eco J C de Geus; Heiner Boeing; Dorret I Boomsma; Anette G Ziegler; P Eline Slagboom; Sandra Hummel; Marian Beekman; Harald Grallert; Søren Brunak; Mark I McCarthy; Ramneek Gupta; Ewan R Pearson; Jerzy Adamski; Leen M 't Hart Journal: Diabetologia Date: 2017-10-25 Impact factor: 10.122
Authors: Sylvain Sebert; Estelle Lowry; Nicole Aumüller; Mercedes G Bermúdez; Lise G Bjerregaard; Susanne R de Rooij; Maneka De Silva; Hanan El Marroun; Nadine Hummel; Teija Juola; Giacomo Mason; Daniela Much; Elena Oliveros; Stavros Poupakis; Nina Rautio; Phillipp Schwarzfischer; Evangelia Tzala; Olaf Uhl; Cornelieke van de Beek; Florianne Vehmeijer; Juan Verdejo-Román; Niko Wasenius; Claire Webster; Leena Ala-Mursula; Karl-Heinz Herzig; Sirkka Keinänen-Kiukaanniemi; Jouko Miettunen; Jennifer L Baker; Cristina Campoy; Gabriella Conti; Johan G Eriksson; Sandra Hummel; Vincent Jaddoe; Berthold Koletzko; Alex Lewin; Maria Rodriguez-Palermo; Tessa Roseboom; Ricardo Rueda; Jayne Evans; Janine F Felix; Inga Prokopenko; Thorkild I A Sørensen; Marjo-Riitta Järvelin Journal: Int J Epidemiol Date: 2019-08-01 Impact factor: 7.196